Angina reassessed: Pain or protector?

Lancet

Volumn 347, Issue 9009, 1996, Pages 1059-1062

  Yellon, Derek M ^a   Baxter, Gary F ^a   Marber, Michael S ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002860685     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Hultgren HN, Peduzzi P. Relation of severity of symptoms to prognosis in stable angina pectoris. Am J Cardiol 1984; 54: 988-93.
2. CASS Investigators. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery, survival data. Circulation 1983; 68: 939-50.
3. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia a delay of cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
4. Topol EJ, Ellis SG. Coronary collaterals revisited: accessory pathway to myocardial preservation during infarction. Circulation 1991; 83: 1084-86.
5. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction. Lancet 1988; ii: 349-60.
6. Yellon DM, Downey JM. Current research views on myocardial reperfusion and reperfusion injury. Cardioscience 1990; 1: 89-98.
7. Kloner RA, Yellon M. Does ischemic preconditioning occur in patients? J Am Coll Cardiol 1994; 24: 1133-42.
8. Yellon DM, Baxter GF. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? J Moll Cell Cardiol 1995; 27: 1023-34.
9. Jenkins DP, Baxter GF, Yellon DM. The pathophysiology of ischemic preconditioning. Pharmacol Res 1995; 31: 1-6.
10. Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by adenosine A1 receptors in rabbit heart. Circulation 1991; 84: 350-56.
11. Cohen MV, Downey JM. Ischaemic preconditioning: can the protection be bottled? Lancet 1993; 342: 6.
12. Przyklenk K, Kloner RA. Role of protein kinase C in ischaemic preconditioning: in search of the "pure and simple truth". Basic Res Cardiol 1996; 91: 41-43.
13. ATP channels in ischaemic preconditioning. Cardiovasc Res 1994; 28: 783-87.
14. + channel? Studies of contractile function following simulated ischemia in an atrial in vitro model. Circ Res 1995; 77: 1030-35.
15. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours following brief ischemia or heat stress is associated with resistance to infarction. Circulation 1993; 88: 1264-72.
16. Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effect of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993; 72: 1293-99.
17. Baxter GF, Goma FM, Yellon DM. Temporal characterisation of the "second window of protection": duration of the anti-infarct effect after ischaemic preconditioning. Circulation 1995; 92 (suppl I): I-389 (abstr).
18. Baxter GF, Marber MS, Yellon DM. Myocardial stress response, cytoprotective proteins and the second window of protection against infarction. In: Wainwright CL, Parratt JR, eds. Myocardial preconditioning. Austin, Texas: R G Landes Co, 1996.
19. Das DK, Maulik N, Moraru I. Gene expression in acute myocardial stress: induction by hypoxia, ischemia, reperfusion, hypethermia and oxidative stress. J Mol Cell Cardiol 1995; 27: 181-93.
20. Hoshida S, Kazuya T, Fuji H, et al. Sublethal ischemia alters myocardial antioxidant activity in canine heart. Am J Physiol 1993; 264: H33-39.
21. Baxter GF, Marber MS, Patel VC, Yellon DM. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 1994; 90: 2993-3000.
22. Baxter GF, Goma FM, Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol 1995; 115: 222-24.
23. Meller ST, Gebhart GF. A critical review of the afferent pathways and the potential chemical mediators involved in cardiac pain. Neuroscience 1992; 48: 501-24.
24. Crea F, Gaspardone A, Kaski JC, Davies G, Maseri A. Relation between stimulation site of cardiac afferent nerves by adosine and distribution of cardiac pain: results of a study in patients with stable angina. J Am Coll Cardiol 1992; 20: 1498-502.
25. Gaspardone A, Crea F, Tomai F, et al. Muscular and cardiac adenosine-induced pain is mediated by A1 receptors. J Am Coll Cardiol 1995; 25: 251-57.
26. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Herrmann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical hemodynamic and metabolic features. Circulation 1990; 82: 2044-51.
27. Cribier A, Korsatz L, Koning R, et al. Improved myocardial response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cardiol 1992; 20: 758-86.
28. + channel blocker. Circulation 1994; 90: 700-05.
29. Marber MS, Joy MD, Yellon DM. Warm-up in angina: is it ischaemic preconditioning? Br Heart J 1994; 72: 213-15.
30. Wayne EJ, Graybiel A. Observations on the effect of food, gastric distension, external temperature, and repeated exercise on angina of effort, with a note on angina sine dolore. Clin Sci 1934; 1: 287-304.
31. Williams DO, Bass TA, Gerwitz H, Most AS. Adaptation to the stress of tachycardia in patients with cornary artery disease: insight into the mechanism of the warm-up phenomenon. Circulation 1985; 71: 687-92.
32. Okazaki Y, Kodama K, Sato H, et al. Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up phenomenon. J Am Coll Cardiol 1993; 21: 1597-604.
33. Cortina A, Ambrose JA, Prieto-Granada J, et al. Left ventricular function after myocardial infarction: clinical and angiographic correlations. J Am Coll Cardiol 1985; 5: 619-24.
34. Behar S, Reicher-Reiss H, Allmader E. The prognostic significance of angina pectoris preceding the occurrence of a first acute myocardial infarction in 4166 consecutive hospitalized patients. Am Heart J 1992; 123: 1481-86.
35. Anzai T, Yoshikawa T, Asakura Y, et al. Effect on short-term prognosis of left ventricular function of angina pectoris prior to first Q-wave anterior wall acute myocardial infarction. Am J Cardiol 1994; 74: 755-59.
36. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation 1995; 91: 291-97.
37. Kloner RA, Shook, T, Pryzklenk K, et al. Previous angina alters in-hospital outcome in TIMI-4: a clinical correlate to preconditioning? Circulation 1995; 91: 37-47.
38. Nakagawa Y, Ito H, Kitakaze M, et al. Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of preconditioning. J Am Coll Cardiol 1995; 25: 1076-83.
39. Anzai T, Yoshikawa T, Asakura Y, et al. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after first Q wave myocardial infarction. J Am Coll Cardiol 1995; 26: 319-27.
40. Marber MS, Baxter GF, Yellon DM. Prodromal angina limits infarct size: a role for ischaemic preconditioning. Circulation 1995; 92: 1061-62.
41. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986; ii: 57-66.
42. The Secondary Prevention Panel. Preventing heart attack and death in patients with coronary disease. Circulation 1995; 92: 2-4.
43. Furburg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-31.
44. Held PH, Yusuf S. Calcium antagonists in the treatment of ischemic heart disease: myocardial infarction. Coron Artery Dis 1994; 5: 21-26.
45. Knatterud GL, Meinert CL, Klimt CR, Osbourne RK, Martin DB. Effects of hypogycemic agents on vascular complications in patients with adult-onset diabetes. JAMA 1971; 217: 777-84.